COMP <GO>
COYA vs LFVN // NET PROFIT MARGIN
Coya Therapeutics Inc. (NASDAQ) VS. Lifevantage Corporation (Delaware) (NASDAQ) • 15-METRIC TALLY: COYA 3
— LFVN 7
▲ NET PROFIT MARGIN LEADER: LFVN
LAST: $3.11 (-3.71%) • MKT CAP: $75.8M
net-margins
-60.00%
LAST: $5.76 (-1.87%) • MKT CAP: $73.9M
net-margins
4.30%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (COYA VS. LFVN)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | COYA | LFVN | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 80.40% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | 29.20% | -64.20 | LFVN | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 5.5x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -11.50% | 14.22% | -25.72 | LFVN | /fcf-yield <GO> |
| Operating Margin | -60.00% | 5.30% | -65.30 | LFVN | /operating-margins <GO> |
| Net Profit Margin ACTIVE | -60.00% | 4.30% | -64.30 | LFVN | /net-margins <GO> |
| Revenue Growth (YoY) | 123.60% | 14.20% | +109.40 | COYA | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.80% | -2.80 | LFVN | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 6.08 | 3.98 | +2.10 | COYA | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 8/9 | -5.00 | LFVN | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 22.0 | 43.2 | -21.20 | LFVN | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 6.3x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $75.8M | $73.9M | $1.9M | COYA | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | COYA REV | LFVN REV | COYA GROSS % | LFVN GROSS % | COYA FCF | LFVN FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $7.9M | $228.5M | — | 80.4% | -$10.7M | $10.5M |
| FY 2024 | $3.6M | $200.2M | — | 79.3% | -$10.3M | $10.0M |
| FY 2023 | $6.0M | $213.4M | — | — | -$11.2M | $6.8M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
COYA // BETA —
LFVN // BETA —